Immunovia AB (publ) (IMMNOV) Plans SEK 63M Rights Issue, 80% Covered

Immunovia will conduct a SEK 63M rights issue of units, subject to EGM approval, with ~SEK 50M (≈80%) covered by undertakings and a bottom guarantee. Proceeds will fund US commercialization of PancreaSure, clinical studies, and working capital.Material DetailsContext by AI AnalystThis is a financin…